Supernus Pharmaceuticals (NasdaqGM:SUPN) Q3 2025 Earnings Call November 04, 2025 04:30 PM ET Speaker4All right. Good afternoon and welcome to the Supernus Pharmaceuticals third quarter 2025 financial results conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Instructions will follow at that time. As a reminder, this conference call is being recorded. I will now turn the conference over to Peter Vozzo of ICR, Investor Relations Rep ...